Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 116,808 | 108,636 | 153,993 | 154,083 | 133,019 |
| Marketable Securities | 337,366 | 360,070 | 362,320 | 428,830 | 273,376 |
| Receivables | 41,139 | 35,399 | 19,312 | 11,237 | 3,507 |
| Inventories | 25,000 | 17,696 | 4,664 | 366 | N/A |
| TOTAL | $529,830 | $531,676 | $548,751 | $603,057 | $414,809 |
| Non-Current Assets | |||||
| PPE Net | 128 | N/A | N/A | N/A | N/A |
| Investments And Advances | 20,146 | 62,627 | 89,938 | 119,520 | 10,029 |
| Other Non-Current Assets | 1,688 | 1,846 | 2,018 | 2,239 | 973 |
| TOTAL | $21,962 | $64,473 | $91,956 | $121,759 | $11,002 |
| Total Assets | $551,792 | $596,149 | $640,707 | $724,816 | $425,811 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 22,925 | 19,435 | 14,149 | 12,116 | N/A |
| Accounts payable and accrued liabilities | 13,826 | 22,136 | 24,037 | 30,857 | 10,404 |
| Accrued Expenses | 77,105 | 71,066 | 55,981 | 60,096 | 48,121 |
| TOTAL | $114,187 | $112,987 | $94,551 | $103,549 | $59,377 |
| Non-Current Liabilities | |||||
| Long Term Debt | 320,985 | 324,413 | 329,644 | 331,565 | N/A |
| Other Non-Current Liabilities | 1,190 | 1,325 | 1,453 | 1,578 | 0 |
| TOTAL | $322,175 | $325,738 | $331,097 | $333,143 | $2 |
| Total Liabilities | $436,362 | $438,725 | $425,648 | $436,692 | $59,379 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,915 | 86,142 | 86,047 | 86,024 | 85,358 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -1,438,566 | -1,377,851 | -1,306,004 | -1,221,158 | -1,126,989 |
| Other shareholders' equity | 525 | 285 | 527 | 163 | 371 |
| TOTAL | $115,430 | $157,424 | $215,059 | $288,124 | $366,432 |
| Total Liabilities And Equity | $551,792 | $596,149 | $640,707 | $724,816 | $425,811 |